
Seventure Partners
Description
Seventure Partners is a prominent European venture capital firm headquartered in Paris, France, recognized for its dual investment strategy across the Digital & Tech and Life Sciences sectors. As an affiliate of Natixis Investment Managers, a global asset manager, Seventure benefits from a robust institutional backing, enabling it to deploy significant capital into innovative companies. The firm has established itself as a key player in the European VC landscape, known for its deep expertise in its target industries and its commitment to fostering growth from early-stage concepts to mature enterprises.
The firm's investment approach spans from seed to growth stages, with a particular emphasis on Series A and B rounds where it typically acts as a lead or co-lead investor. Seventure Partners is known for its hands-on approach, providing not just capital but also strategic guidance and access to its extensive network. Initial investment tickets generally range from €500,000 to €10 million, reflecting their flexibility to support companies at various points in their development lifecycle. This broad range allows them to engage with promising startups as well as more established ventures seeking scale-up capital.
Seventure manages several dedicated funds, each tailored to specific investment themes. A notable example is their Health for Life Capital series, which focuses on the microbiome, nutrition, and health sectors. The Health for Life Capital II fund, for instance, successfully closed at €250 million, underscoring Seventure's significant commitment and leadership in this cutting-edge field. Beyond life sciences, their Digital Ventures fund targets disruptive technologies across various digital domains. Overall, Seventure Partners manages over €900 million in assets under management, demonstrating its substantial financial capacity and long-term vision in supporting the next generation of European innovators.
This structured approach, coupled with their substantial capital base and sector-specific expertise, positions Seventure Partners as a strategic partner for entrepreneurs aiming to scale their businesses in highly specialized and competitive markets. Their commitment to both technological advancement and health innovation highlights their diverse impact on the European startup ecosystem.
Investor Profile
Seventure Partners has backed more than 280 startups, with 18 new investments in the last 12 months alone. The firm has led 99 rounds, about 35% of its total and boasts 67 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Series B rounds (top funding stages).
- Majority of deals are located in France, United States, Germany.
- Strong thematic focus on Biotechnology, Health Care, Software.
- Led 8 rounds in the past year.
- Typical check size: $540K – $10.8M.
Stage Focus
- Series A (25%)
- Series Unknown (24%)
- Series B (20%)
- Seed (14%)
- Series C (11%)
- Series D (3%)
- Post Ipo Equity (1%)
- Series E (1%)
- Private Equity (1%)
Country Focus
- France (55%)
- United States (14%)
- Germany (14%)
- United Kingdom (4%)
- Denmark (3%)
- Ireland (2%)
- The Netherlands (2%)
- Canada (1%)
- Israel (1%)
- Belgium (1%)
Industry Focus
- Biotechnology
- Health Care
- Software
- Therapeutics
- Medical
- Medical Device
- Information Technology
- Pharmaceutical
- Life Science
- Biopharma
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.